Ashish Jain
Plastic and Reconstructive Surgery · Columbus, GANPI 1841281003
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,772 of the $4,607 with a category attached, or 81.9%. 30 manufacturers reported payments, led by AbbVie at 33.6% of the total. 2025 is the largest year on record at $2,144, more than ten times the $176 reported in 2019.
Across 130 payments — averaging $35.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Axogen$1K
- Mentor Worldwide LLC$519
- Integra Lifesciences Corporation$180
- TELA Bio, Inc.$162
- Heron Therapeutics, Inc.$146
- plus $776 from 24 others
What the payments were for
- Travel & lodging$83518%
- Food & beverage$3,77282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $1,547 |
| Axogen | 5 | $1,277 |
| Mentor Worldwide LLC | 19 | $519 |
| Integra Lifesciences Corporation | 5 | $180 |
| TELA Bio, Inc. | 3 | $162 |
| Heron Therapeutics, Inc. | 2 | $146 |
| Sientra, Inc. | 2 | $90 |
| Merz North America, Inc. | 1 | $89 |
| Smith+Nephew | 3 | $70 |
| Vertex | 3 | $63 |
| Solventum Corporation | 2 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| BD | 1 | $38 |
| Sanara Medtech Inc. | 1 | $28 |
| Motiva USA, LLC | 1 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $23 |
| Coopersurgical, Inc. | 1 | $21 |
| Innovation Technologies Inc | 1 | $21 |
| Hydrofera LLC | 1 | $20 |
| Lifenet Health | 1 | $19 |
| Avanos Medical | 1 | $19 |
| Acera Surgical, Inc. | 1 | $19 |
| Kerecis Limited | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| Trevena, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Apyx Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,607 in reported general payments places this provider in the 65th percentile of 83 plastic and reconstructive surgery providers in Georgia.
See all plastic and reconstructive surgery providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 13 | $113 |
| Doxycycline Hyclate | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Columbus
- Tahira PrendergastColumbus$734
- Rajiv SoodAugusta$502K
- Carmen KavaliAtlanta$233K
- Randal RuddermanAlpharetta$207K
- James NamnoumAtlanta$97K
- Michael MirzabeigiAtlanta$71K
- Katherine SantosaAtlanta$65K
- Marc YuneRoswell$64K
- Asaf YalifAlpharetta$43K
- Luther BakerColquitt$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.